Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and S ézary Syndrome
Conditions: Mycosis Fungoides; Sezary Syndrome; Mycosis Fungoides/Sezary Syndrome Intervention: Drug: Tulmimetostat Sponsors: Washington University School of Medicine; MorphoSys AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials